Irvine, CA - A court injunction preventing the sale of Medtronic's CoreValve in Germany went into effect yesterday, the manufacturer of the CoreValve's chief competitor, Edwards Lifesciences, ...
Siegburg, Germany - Percutaneous implantation of the self-expanding CoreValve aortic valve bioprosthesis in the first-ever series of patients shows that the procedure is feasible in those deemed too ...
Leading medical device major Medtronic Inc.'s (MDT) self-expanding CoreValve transcatheter aortic valve system recently exhibited cost efficiency in transcatheter aortic valve replacement (:TAVR) ...
Medtronic's CoreValve system today gained a second indication from the FDA for use in patients with severe aortic stenosis who are at high risk for surgery. The transcatheter aortic valve replacement ...
Add Yahoo as a preferred source to see more of our stories on Google. NEW YORK (AP) -- Medtronic said Monday that a federal appeals court has ruled it can continue selling its CoreValve heart valve ...
The FDA today approved Medtronic's CoreValve transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis who are unable to undergo conventional open-heart surgery.
Ireland-based medical device major Medtronic plc MDT has been in the headlines over the past few weeks owing to multiple regulatory approvals and the release of positive study results, particularly ...
Meta-Analysis of Seven International Clinical Registries Presented at EuroPCR 2011 Late-Breaking Presentation PARIS – A late-breaking presentation about transcatheter aortic valve implantation (TAVI) ...
FDA has cleared the way for Medtronic's CoreValve to be used in more patients in the United States. The agency on Monday announced a new indication for CoreValve in which the device can be used in ...
Medtronic, Inc. 's ( MDT) CoreValve transcatheter aortic valve replacement (TAVR) system continues to provide efficient treatment at two years for extreme-risk patients, the company announced at the ...
Two high-profile trials of transcatheter aortic valve replacement (TAVR) were presented at the 2014 ACC Scientific Sessions in Washington, DC, USA and published online in late March. Both the ...
Approximately 1 in 3 patients with severe aortic stenosis who undergo transcatheter aortic valve implantation (TAVI) with the CoreValve device will require a permanent pacemaker within 30 days of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results